DE3577562D1 - RENIN INHIBITING COMPOUNDS WHICH STATINE CONTAINS OR DERIVATIVES. - Google Patents

RENIN INHIBITING COMPOUNDS WHICH STATINE CONTAINS OR DERIVATIVES.

Info

Publication number
DE3577562D1
DE3577562D1 DE8585301691T DE3577562T DE3577562D1 DE 3577562 D1 DE3577562 D1 DE 3577562D1 DE 8585301691 T DE8585301691 T DE 8585301691T DE 3577562 T DE3577562 T DE 3577562T DE 3577562 D1 DE3577562 D1 DE 3577562D1
Authority
DE
Germany
Prior art keywords
alkyl
glutamic acid
lys
cycloalkylalkyl
phe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585301691T
Other languages
German (de)
Inventor
Jasjit Singh Bindra
Edward Fox Kleinman
Robert Louis Rosati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE3577562D1 publication Critical patent/DE3577562D1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/14Angiotensins: Related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

Polypeptides of formula (I) and their salts are new. R-W-W'-NH-CHR2-CHR3-CH2-COR1 (I) W = Phe, His, Leu, Tyr, 1-naphthyl-Ala or 2-phenylmethyl 2-phenylmethylpropionylene; W' = Phe, His, Leu, Tyr or Nle; when W = Phe and W' = His, then the peptide link between W and W' may be replaced by -CH(1-4C)Alkyl-NH-; R = H, amino-protecting acyl of molecular wt. up to 500, or Pro or pGlu both amino protected; R2 = H, 1-6C alkyl, Ph, 4-7C cycloalkyl, Ph-(1-3C)alkyl or 5-10C cycloalkylalkyl; R3 = OH, NH2, NHR9, NHCOR9, OR9 or OCOR9; R9 = 1-4C alkyl; R1 = A-E-B; a gp. of formula (II); NH2; 1-4C alkoxy; 5-benzylipiperazin-1-yl; 1,2,3,4-tetrahydroquinolin-1-yl or -2-yl; 1,2,3,4-tetrahydro-3-aminocarbonyl isoquinolin-2-yl or the corresp. 3-methoxycarbonyl gp.; 1,2,3,4,5,6,7,8-decahydro-3-methoxycarbonyl isoquinolin-2-yl; 2-methoxycarbonylpyrrolidin -1-yl; 2-aminocarbonylpyrrolindin-1-yl; 4-phenylmethylpiperidin-1-yl; Pro-B; or Lys-B; -X-NH-CHZ-(CH2)n-Q-CHZ1-(CH2)m-Y (II) A = Lys or Pro or when R3 = NH2, Ile; E = Phe, Gly, Ala, Val, Leu, Ile, Lys, Orn, Arg, Asp opt. gamma-esterified or Glu opt. delta-esterified; B = OR4, NR4R5, glutamic acid (-OR4)2, glutamic acid (-OR4)(-NR4R5) or glutamic acid (-NR4R5)2; R4, R5 = H, 1-4C alkyl, Ph-(1-3C)alkyl or 5-10C cycloalkylalkyl; X = absent or Ala, Ile, Lys, Pro, Orn, Arg, N-(1-4C alkyl)- or N,N-(di-(1-4C) alkyl)-Lys or -Orn; Z, Z1 = H, 1-6C alkyl, 4-7C cycloalkyl, 5-10C cycloalkylalkyl or Ph-(1-3C)alkyl; n, m = 0-6; Q = CH2, CH=CH, O, NH, CH(OH) or CO; Y = Me, Ph, COOR6, CONR6R7, NH2, benzyloxycarbonylamino, CO-glutamic acid (-OR6)2, CO-glutamic acid (OR6)(NR6R7) or CO-glutamic acid (-NR6R7); R6, R7 = H, 1-4C alkyl, Ph-(1-3C)alkyl or 5-10C cycloalkylalkyl.
DE8585301691T 1984-03-12 1985-03-12 RENIN INHIBITING COMPOUNDS WHICH STATINE CONTAINS OR DERIVATIVES. Expired - Fee Related DE3577562D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58827984A 1984-03-12 1984-03-12

Publications (1)

Publication Number Publication Date
DE3577562D1 true DE3577562D1 (en) 1990-06-13

Family

ID=24353222

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585301691T Expired - Fee Related DE3577562D1 (en) 1984-03-12 1985-03-12 RENIN INHIBITING COMPOUNDS WHICH STATINE CONTAINS OR DERIVATIVES.

Country Status (13)

Country Link
KR (1) KR870000371B1 (en)
AT (1) ATE52519T1 (en)
DE (1) DE3577562D1 (en)
ES (1) ES8606397A1 (en)
GR (1) GR850626B (en)
HU (1) HU196833B (en)
IE (1) IE57862B1 (en)
IL (1) IL74572A (en)
NO (1) NO850975L (en)
NZ (1) NZ211403A (en)
PH (1) PH23769A (en)
YU (1) YU46085A (en)
ZA (1) ZA851832B (en)

Also Published As

Publication number Publication date
YU46085A (en) 1988-02-29
ZA851832B (en) 1986-10-29
IL74572A (en) 1989-09-28
IE57862B1 (en) 1993-05-05
ES541194A0 (en) 1986-04-16
ES8606397A1 (en) 1986-04-16
NO850975L (en) 1985-09-13
ATE52519T1 (en) 1990-05-15
HU196833B (en) 1989-01-30
GR850626B (en) 1985-07-11
NZ211403A (en) 1989-01-27
IE850640L (en) 1985-09-12
IL74572A0 (en) 1985-06-30
KR850006940A (en) 1985-10-25
KR870000371B1 (en) 1987-03-06
HUT37442A (en) 1985-12-28
PH23769A (en) 1989-11-03

Similar Documents

Publication Publication Date Title
KR890014578A (en) Peptide compound, preparation method thereof and pharmaceutical composition containing same
WO1996016981A3 (en) Peptide compounds for prevention and/or treatment of no-mediated diseases
CA2192725A1 (en) Camptothecin derivatives
DE3579188D1 (en) DIAMINO ACID DERIVATIVES.
GB9519077D0 (en) New heterocyclic compounds
ES2012720A6 (en) Acid addition salts of amidated taurine or glycine, their preparation and use
DE3577562D1 (en) RENIN INHIBITING COMPOUNDS WHICH STATINE CONTAINS OR DERIVATIVES.
DE3687405D1 (en) AMINO ACID DERIVATIVES.
NO894720L (en) PHARMASOEYTIC ACTIVE PROTEIN.
KR930703348A (en) Factor II (IIa) Inhibitors
DE3586936D1 (en) Peptide.
FR2575163B1 (en) REDUCED TRI- AND TETRAPEPTIDES INHIBITORS OF GASTRIC SECRETION, PROCESS FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE92078T1 (en) PHARMACOLOGICALLY ACTIVE PEPTIDES.
ATE70454T1 (en) PRODUCT CONTAINING VINCRISTIN.
TW340849B (en) Novel cyclopeptides and pharmaceutical compositions as integrin inhibitors comprizing the same
ATE221897T1 (en) PLATELET AGGREGATION INHIBITORS CONTAINING C-TERMINAL AMINO ACID RESIDUES WITH AMINERGIC SIDE CHAINS

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee